Literature DB >> 26844829

Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.

Josiah Gerdts1, Daniel W Summers2, Jeffrey Milbrandt3, Aaron DiAntonio4.   

Abstract

Wallerian axon degeneration is a form of programmed subcellular death that promotes axon breakdown in disease and injury. Active degeneration requires SARM1 and MAP kinases, including DLK, while the NAD+ synthetic enzyme NMNAT2 prevents degeneration. New studies reveal that these pathways cooperate in a locally mediated axon destruction program, with NAD+ metabolism playing a central role. Here, we review the biology of Wallerian-type axon degeneration and discuss the most recent findings, with special emphasis on critical signaling events and their potential as therapeutic targets for axonopathy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26844829      PMCID: PMC4742785          DOI: 10.1016/j.neuron.2015.12.023

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  107 in total

1.  TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog.

Authors:  Qing Zhang; Christian M Zmasek; Xiaohui Cai; Adam Godzik
Journal:  Dev Comp Immunol       Date:  2010-11-24       Impact factor: 3.636

2.  Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury.

Authors:  Vera Valakh; Erin Frey; Elisabetta Babetto; Lauren J Walker; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2015-02-26       Impact factor: 5.996

3.  Microtubule depolymerization in Caenorhabditis elegans touch receptor neurons reduces gene expression through a p38 MAPK pathway.

Authors:  Alexander Bounoutas; John Kratz; Lesley Emtage; Charles Ma; Ken C Nguyen; Martin Chalfie
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

4.  A Toll-interleukin 1 repeat protein at the synapse specifies asymmetric odorant receptor expression via ASK1 MAPKKK signaling.

Authors:  Chiou-Fen Chuang; Cornelia I Bargmann
Journal:  Genes Dev       Date:  2004-12-29       Impact factor: 11.361

5.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

6.  Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons.

Authors:  Daniel W Summers; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

7.  Regulation of DLK-1 kinase activity by calcium-mediated dissociation from an inhibitory isoform.

Authors:  Dong Yan; Yishi Jin
Journal:  Neuron       Date:  2012-11-08       Impact factor: 17.173

8.  The Caenorhabditis elegans microtubule minus-end binding homolog PTRN-1 stabilizes synapses and neurites.

Authors:  Jana Dorfman Marcette; Jessica Jie Chen; Michael L Nonet
Journal:  Elife       Date:  2014-02-25       Impact factor: 8.140

9.  Rescue of peripheral and CNS axon defects in mice lacking NMNAT2.

Authors:  Jonathan Gilley; Robert Adalbert; Gang Yu; Michael P Coleman
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

10.  Combining comparative proteomics and molecular genetics uncovers regulators of synaptic and axonal stability and degeneration in vivo.

Authors:  Thomas M Wishart; Timothy M Rooney; Douglas J Lamont; Ann K Wright; A Jennifer Morton; Mandy Jackson; Marc R Freeman; Thomas H Gillingwater
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

View more
  133 in total

1.  Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen.

Authors:  Jessica A Linderman; Mariko Kobayashi; Vinayak Rayannavar; John J Fak; Robert B Darnell; Moses V Chao; Angus C Wilson; Ian Mohr
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

Review 2.  Synaptic homeostats: latent plasticity revealed at the Drosophila neuromuscular junction.

Authors:  Pragya Goel; Dion Dickman
Journal:  Cell Mol Life Sci       Date:  2021-01-15       Impact factor: 9.261

3.  The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

4.  The axon degeneration gene SARM1 is evolutionarily distinct from other TIR domain-containing proteins.

Authors:  Harsha Malapati; Spencer M Millen; William J Buchser
Journal:  Mol Genet Genomics       Date:  2017-04-26       Impact factor: 3.291

5.  Toll-like receptor pathway evolution in deuterostomes.

Authors:  Michael G Tassia; Nathan V Whelan; Kenneth M Halanych
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 6.  Roles of palmitoylation in axon growth, degeneration and regeneration.

Authors:  Sabrina M Holland; Gareth M Thomas
Journal:  J Neurosci Res       Date:  2017-02-02       Impact factor: 4.164

7.  TIR Domain Proteins Are an Ancient Family of NAD+-Consuming Enzymes.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aldrin Kay Yuen Yim; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Curr Biol       Date:  2018-01-25       Impact factor: 10.834

8.  Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation.

Authors:  Pascal Röderer; Lara Klatt; Felix John; Verena Theis; Konstanze F Winklhofer; Carsten Theiss; Veronika Matschke
Journal:  Mol Neurobiol       Date:  2018-03-16       Impact factor: 5.590

Review 9.  Apoptosis versus axon pruning: Molecular intersection of two distinct pathways for axon degeneration.

Authors:  Matthew J Geden; Selena E Romero; Mohanish Deshmukh
Journal:  Neurosci Res       Date:  2018-11-16       Impact factor: 3.304

Review 10.  Axon degeneration: context defines distinct pathways.

Authors:  Matthew J Geden; Mohanish Deshmukh
Journal:  Curr Opin Neurobiol       Date:  2016-05-16       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.